Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 5, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of a supplement called glutamine on patients with gastric cancer who have had surgery to remove part or all of their stomach (a procedure known as gastrectomy). The main goal is to see if glutamine can help reduce muscle loss, a condition known as sarcopenia, which can occur after such surgery. The study will also look at how glutamine affects patients' physical activity, weight changes, and overall nutrition.
To participate, you need to be an adult who has been diagnosed with gastric cancer and is scheduled for gastrectomy. However, if you have severe liver or kidney problems, cannot eat normally after surgery, or are unable to wear a device that tracks your activity, you would not qualify for this trial. If you join, you can expect to receive glutamine supplements and be monitored for changes in your health and nutrition over time. This study is currently recruiting participants, and it's a chance to contribute to important research that may help improve recovery for future gastric cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult gastric cancer receiving gastrectomy
- Exclusion Criteria:
- • Hepatic insufficiency
- • Renal insufficiency
- • can not tolerate oral or enteral feeding 7 days after gastrectomy
- • can not receive computed tomograph
- • can not waer the wearable devices
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Jin-Ming Wu, MD
Principal Investigator
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported